Clinical Trial Update: Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral ferric maltol versus IV iron for iron deficiency anemia in inflammatory bowel disease completed with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• Ferric Maltol (ferric maltol)

Snippet

Sponsor: Shield Therapeutics | Conditions: Anemia, Iron-Deficiency, Inflammatory Bowel Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-02-24